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In Drosophila, ecdysone hormone levels determine
the timing of larval development. Its production is
regulated by the stereotypical rise in prothoracico-
tropic hormone (PTTH) levels. Additionally, ecdysone
levels can also bemodulated by nutrition (specifically
by amino acids) through their action on Drosophila
insulin-like peptides (Dilps). Moreover, in glia,
amino-acid-sensitive production of Dilps regulates
brain development. In this work, we describe the
function of an SLC7 amino acid transporter, Sobre-
mesa (Sbm). Larvae with reduced Sbm levels in glia
remain in third instar for an additional 24 hr. These
larvae show reduced brain growth with increased
body size but do not show reduction in insulin
signaling or production. Interestingly, Sbm downre-
gulation in glia leads to reduced Ecdysone produc-
tion and a surprising delay in the rise of PTTH levels.
Our work highlights Sbm as amodulator of both brain
development and the timing of larval development
via an amino-acid-sensitive and Dilp-independent
function of glia.
INTRODUCTION
Members of the SLC7 family of proteins are membrane-bound
transporters dedicated to the passage of amino acids. They
are classified into two subfamilies: cationic amino acid trans-
porters (CATs), facilitating diffusion of cationic amino acids,
and L-type amino acid transporters (LATs), which are mostly
specific exchangers. CATs act as single molecules, while LATs
form heterodimeric amino acid transporters (HATs) together
with members of the SLC3 family of proteins. The HAT is formed
through a disulfide bridge between the LAT (12 transmembrane
domain light subunit) and the SLC3 subunit (heavy subunit),
involving a cysteine positioned in the external loop between
the III and IV transmembrane domains of the LAT (Fotiadis
et al., 2013; Verrey et al., 2004). Based on the structural
characteristics of these proteins, bioinformatics analysis of the3156 Cell Reports 24, 3156–3166, September 18, 2018 ª 2018 The A
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would code for proteins with LAT characteristics, namely gen-
derblind, minidiscs, JhI-21, CG1607, and CG9413 (Augustin
et al., 2007; Reynolds et al., 2009). While the expression and
function of a D. melanogaster CAT transporter Slimfast has
been extensively studied (Bjordal et al., 2014; Cheng et al.,
2011; Colombani et al., 2003; Okamoto and Nishimura, 2015;
Shim et al., 2012), LATs have been a subject of less scrutiny,
and not all five LATs have been functionally characterized.
In the present study, we focus on CG9413, a yet-undescribed
putative Drosophila LAT.
SLC7 amino acid transporters can have a potentially crucial
role impacting the physiology of an organism. They can serve
the uptake of amino acids to directly feed the protein synthesis
machinery or impact the reuptake of amino acids in excretory
organs such as the gut and kidneys (Palacı´n et al., 2005). Related
to this, they can feed amino acids into signaling pathways
that control the production, release, or response to hormones
that regulate amino-acid-sensitive processes such as growth,
developmental timing, or feeding, thus functioning as amino
acid sensors (Fotiadis et al., 2013; Miguel-Aliaga, 2012).
Through amino acid sensors, the nutritional value of food is
coupled to the hormonal signals that coordinate growth and
developmental timing. In Drosophila, insulin-like peptides (Dilps)
activate the insulin-like signaling (IIS) pathway in target tissues
and induce cellular growth and proliferation (Edgar, 2006; Mirth
and Riddiford, 2007). Their production and release depends on
both local and remote signals from nutrient sensors that assess
the nutritional status of the organism (Delanoueet al., 2016;Ge´m-
inard et al., 2009; Okamoto and Nishimura, 2015; Rajan and Per-
rimon, 2012). Developmental timing, determined by rises of the
molting hormone ecdysone and the stereotyped rise in the pro-
thoracicotropic hormone (PTTH) (McBrayer et al., 2007), is also
coupled to nutrition through Dilp signaling (Colombani et al.,
2005; Mirth et al., 2005). CAT Slimfast functions as a general
amino acid transporter and, in that capacity, as a nutrient sensor
(Colombani et al., 2003). It is expressed in important organs for
growth control, such as in fat body and theCNS, and feeds amino
acids into the signaling pathways that ultimately impact the
production and release of Dilps (Bjordal et al., 2014; Cheng
et al., 2011; Colombani et al., 2003; Okamoto and Nishimura,
2015). Interestingly, LAT-1 Minidiscs and JhI-21 have recentlyuthors.
commons.org/licenses/by/4.0/).
been shown to function as leucine sensors in the insulin-produc-
ing cells of the larva, thus having a role in the regulation of growth
and metabolism (Manie`re et al., 2016; Ziegler et al., 2018).
In addition to their role as amino acid sensors, SLC7 trans-
porters can also impact neurotransmission, since they can serve
in the maintenance of the concentrations of specific amino acids
that function as neurotransmitters or as precursors for neuro-
transmitters (Featherstone, 2011). In the case of LATs, Gender-
blind is expressed in some glia surrounding glutamatergic
neurons, where it regulates the level of extracellular glutamate
(Augustin et al., 2007; Piyankarage et al., 2008). Furthermore,
Genderblind and also JhI-21 control ionotropic glutamate recep-
tor (iGluR) clustering at the neuromuscular junction (NMJ) (Au-
gustin et al., 2007; Ziegler et al., 2016), implicating an essential
role for both LATs in neurotransmission. Moreover, genderblind
disruption in adults impacts pheromonal perception inmales and
food odor detection in both sexes (Grosjean et al., 2008).
In the present study, we focus on CG9413, one of the less-
studiedDrosophila putative LATs.We show evidence supporting
its capacity to form a HAT together with the Drosophila SLC3
protein CD98hc. We confirm that it is expressed in the gut and
in the CNS of larvae. Moreover, we reveal that expression of
CG9413, here named sobremesa (sbm), is crucial for proper
larval growth, feeding, and timing of pupation. Most importantly,
sbm expression in glia is a key factor for proper timing of
development and brain growth. Sbm glial knockdown provokes
a reduction in PTTH somatic levels, revealing an unknown glial
function and a possible axis of amino-acid-sensitive communi-
cation between glia and PTTH-producing cells.
RESULTS
Sobremesa (CG9413 - Sbm) ShowsCharacteristics of an
SLC7 Amino Acid Transporter
To study sbm gene expression in D. melanogaster, we per-
formed diagnostic PCRs over total cDNA fromw1118 control flies
(Figure S1A), followed by cloning and sequencing of CDSs. We
confirmed the existence and predicted sequences listed in
FlyBase of its 4 transcripts: sbm-RA, RB, RC, and RD. Sbm-
PA and PB would have a structure that could interact with the
putative Drosophila SLC3 protein, the HAT heavy subunit
CD98hc. On the contrary, Sbm-PC and PD would be shorter
proteins with atypical cysteine locations possibly not compatible
for this interaction (Figure 1A).
To visualize these possible physical interactions, we made
tagged versions of the different isoforms. CD98hc fused to hem-
agglutinin (CD98hc:HA) expressed alone in S2 cells appears
localized in part to the plasma membrane and provokes
membrane extensions resembling filopodia and lamelipodia
(Figures 1D and S1C). FLAG:Sbm PA and PB expressed alone
also show this localization, while PC and PD localize mainly
in big clumps inside the cell or near the cell surface. None of
the FLAG:Sbm variants provoke any change in the normal
morphology of S2 cells (Figure 1B). Co-expression of
CD98hc:HA with either FLAG:Sbm PA or PB showed colocaliza-
tion of FLAG:Sbm variants with CD98hc:HA at the plasma mem-
brane, supporting the hypothetical interaction between the two
proteins (Figure 1C). Western blots revealed either with FLAGor HA antibodies show a band at the expected size for the
heterodimer. Breaking the disulfide bridges by adding a reducing
agent (DTT) effectively abolished the heterodimer band,
displaying clear bands corresponding to the monomers (Figures
1E and S1B). On the contrary, co-expression of PC or PD
FLAG:Sbm and CD98hc:HA variants leads to a localization in
dots inside the cell with no visible colocalization of these 2 sub-
units and does not affect cell morphology (Figure 1C). Further-
more, FLAG:Sbm-PC and PD do not produce the dimer size
bands expected when co-expressed with CD98hc:HA (Fig-
ure S1B). These results strongly suggest that Sbm-PA and PB
are able to interact with CD98hc to form a heterodimer at the
plasmamembrane, while the shorter proteins (PC and PD) would
not form a heterodimer with CD98hc and may even interfere with
its localization. The interaction between Sbm and CD98hc con-
stitutes important evidence to confirm Sbm as an SLC7A family
member and also that they form a complex, which potentially
functions as a HAT to transport amino acids.
sbm Expression Pattern
To explore sbm expression pattern in further detail at the larval
stage, we constructed a Sbm-Gal4 line and produced an anti-
body that would detect all Sbm proteins. sbm is expressed
in the CNS, both in glia and neurons (Figures 1F, 1G, and
S1D–S1G), and the gut (Figures 1H and S1H). Distinct signal
can be seen in subperineurial and cortex glia (Figures 1F, S2A,
and S2B), but not in other glial subtypes (Figures S2C–S2F),
and in a cluster of four neurons in each brain hemisphere that
project to the corpora cardiaca in the ring gland (Figures 1G
and S1D–S1F). The expression pattern observed with an anti-
body against Sbm is supported by that observed with the Gal4
line (Figures S1F–S1H). Noteworthy, the antibody signal appears
localized in part to the membrane of the cells (Figures 1F, 1G,
S2A, and S2B), supporting the predicted structure and function
of the protein as a membrane transporter.
Downregulation of sbm in Glia Delays Development and
Affects Growth Differentially Among Organs
Since sbm is expressed in several larval organs and cell types,
we next screened for the effects of sbm downregulation in these
restricted expression domains. To that end, we drove expression
of RNAi in the gut using the myo1D-Gal4 driver line (Figure 2A),
panneuronally by combining Appl-Gal4 and Syb-Gal4 lines (Fig-
ure 2B) or specifically in the Sbm immunoreactive cluster of neu-
rons that project to the corpora cardiaca with the 18E11-Gal4
line (Figure 2C), and finally in glia with Repo-Gal4 line (Sepp
et al., 2001; Yuasa et al., 2003) (Figure 2D). Downregulation
with two independent RNAi lines strongly reduces sbm mRNA
levels to the same extent (Figures S4A and S4B) and significantly
decreases the protein levels exclusively in the cellular typewhere
the expression is directed (Figures S3A–S3D). Notoriously, spe-
cific downregulation of sbm with these two independent RNAi
lines in glia provoked a strong developmental delay of almost
24 hr (Figures 2D, S4D, and S5D), while the downregulation of
sbm on any of the other expression domains did not affect devel-
opmental timing (Figures 2A–2C). This phenotype led us to name
this gene sbm, a Spanish word that translates as ‘‘the extended
period of time spent at the table conversing long after the mealCell Reports 24, 3156–3166, September 18, 2018 3157
Figure 1. Cellular Localization, Interaction
with CD98hc, and Expression Pattern of so-
bremesa (CG9413 – sbm)
(A) Putative secondary structure of the translation
products of each sbm mRNA. The magenta
asterisk shows the position of the FLAG tag. Each
circle represents an amino acid, and red circles
represent extracellular cysteine.
(B) Expression of each FLAG-tagged protein in S2
cells revealed by staining against FLAG (magenta).
PA and PB, but not PC and PD, localize in part to
the plasma membrane, and PC and PD form
clumps inside the cell.
(C) Coexpression of each FLAG:Sbm protein with
CD98hc:HA (blue, Hoescht; magenta, FLAG;
green, HA) in S2 cells. PA and PB, but not PC and
PD, colocalize with CD98hc:HA (cyan and yellow
arrowheads for FLAG and HA signal, respectively).
PC and PD alter CD98hc localization and abolish
the membrane extensions phenotype provoked by
CD98hc expression.
(D) Putative structure of CD98hc (left) and immu-
nostaining of S2 cells expressing CD98hc:HA de-
picting the membrane extension phenotype (right).
The green asterisk shows the position of the HA tag
on CD98hc.
(E) Western blot of coexpressing FLAG:Sbm-PA
and CD98hc:HA cell extracts in the presence (+)
and absence () of reducing agent (DTT), revealed
with anti-FLAG and anti-HA antibodies. The ex-
pected position of the heterodimer and monomer
bands are pointed based on the molecular
weight marker. Heterodimer bands are revealed
in the absence of DTT and disappear with DTT,
while monomer bands behave in the opposite way
(expected molecular weights: Sbm-PA, 57.6 kDA;
CD98hc, 62.7 kDa).
(F) Immunostaining in larval brains of Repo-Gal4 >
UAS-CD8:GFP reveals expression of Sbm in glia,
apparently on the membrane of the subperineurial
and cortex glia (Sbm, magenta; GFP, green; Repo,
blue; in F00, yellow letters and broken line squares
signal the corresponding positions of insets a–d).
(G) Sbm (green) is expressed in a group of neurons
(somas, hollow arrowhead; projections, filled ar-
rowheads) projecting to the corpora cardiaca (cc) portion of the ring gland (RG). Counterstaining against GFP (magenta) in a P0206-Gal4 > UAS-CD8:GFP line
delimits the RG.
(H) Immunostaining against Sbm (magenta) shows the expression of Sbm in part of the hindgut; counterstaining with phalloidin (green) is shown to delineate the
tissue.has actually ended.’’ This developmental delay was specific to
the third larval instar, since molting from the second to the third
instar was not delayed (Figure S4C). Downregulation of Sbm us-
ing specific glial subtype drivers failed to reproduce the develop-
mental delay phenotype observed with the general glial driver
Repo-Gal4 (Figure S5A), suggesting that sbm function could
be important in several glial subtypes and that its downregulation
in one could be compensated by others. It is interesting to note
that a very strong ubiquitous knockdown of the gene with the
Tubulin-Gal4 driver provokes an extended third larval instar in
which larvae remain in the feeding substrate for up to 10 days
and never commence wandering or pupation (Figures S5B and
S5C); this suggests that Sbm could have a function in other tis-
sues apart from glia and the CNS.3158 Cell Reports 24, 3156–3166, September 18, 2018Surprisingly, despite the developmental delay in Repo >
SbmRNAi flies, larval weight was notably increased, especially
at 96 hr after egg laying (hAEL), a time corresponding to the
last 24 hr of the third larval instar of controls (Figure 2E), result-
ing in individuals of bigger final size. This was also attested
by an increase in pupal volume (Figures 2F and S4E) and
adult male weight (Figure 2G), which also had bigger wings
composed of bigger and more numerous cells (Figures
2H–2J). Also noteworthy is that food intake and the rate of
food incorporation to body mass was increased in Repo >
SbmRNAi flies (Figure 2K.) Contrary to the glial knockdown of
Sbm, its overexpression does not lead to a very significant
developmental delay and has a negative effect on growth (Fig-
ures S5D and S5E).
Figure 2. sbm Downregulation in Glia Has
a Specific Effect on Developmental Timing
and Growth
(A–C) Proportion of larvae pupated through time
after downregulation of sbm in the gut (A; myo1D-
Gal4), panneuronally (B; Appl-Gal4; Syb-Gal4),
and in the group of neurons that project to the
corpora cardiaca (C; 18E11-Gal4). In all cases, a
t test was performed, and n.s. indicates nonsig-
nificant differences. t values are as follows: t = 2.56
(A, n = 8), t = 1.95 (B, n = 9), and t = 1.79 (C, n = 5).
(D–K) Downregulation of sbm in glia (via expression
of the RNAi with Repo-Gal4) leads to a delay to
pupation, an increase in final size, and an increase
in feeding.
(D) Proportion of larvae pupated through time
(t test, t = 8.07; **p < 0.0001; n = 15).
(E) Larval weight (in milligrams) at different time
points through development (two-way ANOVA;
data were transformed to natural logarithm [ln] to
fulfill the test criteria; p < 0.0001, F = 18.99; points
with different letters signify that they are signifi-
cantly different with p < 0.05 in a Tukey post-test;
n = 15–22 per age and genotype).
(F) Estimated pupal volume (in cubic centimeters)
(t test, t = 6.09; **p < 0.0001; n = 15). The picture
on the right shows example individuals of each
genotype.
(G) Adult male fly weight (mg) (t test, t = 7.32;
**p < 0.0001; n = 36–65).
(H) Male fly wing area (mm2) (t test, t = 5.51;
**p < 0.01; n = 3).
(I) Hair density on male fly wings (t test, t = 2.63;
*p < 0.05; n = 3).
(J) Estimated total number of hairs per male wing
(t test, t = 4.03; **p < 0.01; n = 3).
(K) Amount of food (mg) ingested by 22-hr-old
synchronized third-instar larvae normalized by
their mass (mg) (t test, t = 3.28; *p < 0.05; n = 5).
In all graphs, data represent mean ± SEM, and the
percentages above the bars indicate the difference
in respect to the control. hAEL, hours after egg
laying.In order to study if the increased larval weight was a conse-
quence of a general elevated growth rate, we analyzed the size
of different organs. We found that not all organs present the
same growth rate nor final size differences between controls
and Repo > SbmRNAi larvae as the whole animals do. In the
case of fat body, an endoreplicative tissue, the cell area behaved
similarly to the whole larva, with bigger cells during the early
parts of the third larval instar (80 and 96 hAEL), a marked in-
crease in size in the Repo > SbmRNAi larvae relative to controls
in the last hours (102 hAEL), and no further rise during the extraCell Reportstime before pupation (120 hAEL) (Fig-
ure 3 A). Conversely, the wing imaginal
disc area was always significantly smaller
in RNAi-treated larvae (a diploid tissue)
than in controls, though growth rates
were similar (80–102 hAEL). Nevertheless,
since the growth rate wasmaintained dur-
ing the extra hours they spend as larvae,the final size of the imaginal disc is bigger (120 hAEL), which
could in turn account for the bigger wings measured in adults
(Figures 3B and 2H). Finally, to our surprise, we observed that
the brains of Repo > SbmRNAi larvae were much smaller than
that of controls. Even though second-instar larvae do not show
statistically significant differences in estimated brain lobe vol-
ume (52 hAEL) compared to controls, by the first day of the larval
third-instar, their brain size has not changed, much resulting in
a brain that is 72.2% smaller than that of controls (80 hAEL).
This difference in growth rate is further maintained though time24, 3156–3166, September 18, 2018 3159
Figure 3. Effects of sbm Downregulation in
Glia on Various Tissue Growth
(A) Fat body cell area (mm2) through time and
representative pictures of fat bodies stained with
Sudan black to show fat accumulation (the red
broken line exemplifies some measured cells in
each picture) (two-way ANOVA and Duncan post-
test, p < 0.01, F = 6.26; n = 4–5.)
(B) Wing imaginal disc area (mm2) through time
and representative pictures (Two-Way ANOVA
with a Duncan Post-Test, interaction between the
variables time and genotype is not significant
so only statistical differences between time points
is shown in the graph, p < 0.0001, F = 123.13;
n = 11–15).
(C) Estimation of larval single brain lobe
volume (mm3) through time and representative
pictures (two-way ANOVA with a Tukey post-test,
p < 0.0001, F = 22.55; DMS = 0.34; n = 4–5.)
In all statistical analyses, data were transformed to
natural logarithm (ln) to fulfill the test criteria. In all
graphs, points with different letters signify that they
are significantly different (p < 0.05). Data represent
mean ± SEM; the percentages above points indi-
cate the difference in respect to the control. hAEL,
hours after egg laying.(96 and 102 hAEL), and while Repo > SbmRNAi larvae spend
almost 24 extra hours eating and growing (120 hAEL), their brain
never reaches the final control size (Figures 3C and S6A). Obser-
vations of the anatomical features (Dearborn and Kunes, 2004;
Ngo et al., 2017) of the brain of the Sbm-knockdown larvae
through these time points show that brain development is de-
layed compared to controls (Figure 4A). This is also highlighted
by the differences in the number of dividing cells. We found
that Repo > SbmRNAi larvae have significantly fewer prolifer-
ating cells than controls at both 96 and 120 hAEL. This has nega-
tive consequences, at least on the number of glial cells, which
are significantly less numerous in Repo > SbmRNAi larvae at
120 hAEL, but not at 96 hAEL (Figures 4B and 4C).
To sum up, reduced levels of Sbm in glia produce a develop-
mental delay that results in heavier larvae, bigger wing imaginal
discs, and bigger fat body cells but a smaller brain, possibly
due to a decrease in cell proliferation with delayed conse-
quences on neuron and glial cell numbers. Extension of the larval
stage is accompanied by larvae staying longer in the food, result-
ing in bigger pupae and bigger and heavier adult flies.3160 Cell Reports 24, 3156–3166, September 18, 2018Downregulation of sbm in Dilp6-
Expressing Glia Leads to
Developmental Delay, but General
Glial Knockdown Does Not Lead to
Expected Effects of Dilp6
Deficiency
Larval growth is primarily regulated by
eight insulin-like peptides (Dilp1–8). Since
they all act through a single insulin recep-
tor, regulation of growth is achieved
through the spatial, temporal, and cir-
cumstantial regulation of their productionand release. One such peptide, Dilp6, is produced by glial
cells in a nutrient-sensitive manner and regulates brain growth
(Okamoto and Nishimura, 2015; Sousa-Nunes et al., 2011).
This led us to explore if the downregulation of sbm in Dilp6-
producing glia could reproduce the developmental-delay pheno-
type observed with the panglial driver Repo. Expression of Sbm
RNAi with a Dilp6-Gal4 line (which drives expression in glial cells
of the subperineurial glia and others [possibly the cortex glia
(Okamoto and Nishimura, 2015) and fat body]) significantly
delayed the onset of pupation by11 hr (Figure 5A), a slighter ef-
fect thanwith the general glial driver. This delaywas fully rescued
when Gal4 activity was blocked in glial cells co-expressing
Gal80, indicating that the observed developmental delay in
Dilp6 > SbmRNAi larvae depends on deregulation of Sbm in
Dilp6+ glial cells. (Figure 5A). Plus, larvae expressing the RNAi
in the fat body did not display a pupation time statistically
different from controls (Figure 5B).
Amino acids enter glial cells via CAT transporter Slif, which
functions as an amino acid sensor, activating the TOR signaling
pathway and positively regulating dilp6 expression (Okamoto
Figure 4. Effects of Sbm Downregulation
in Glia on Larval Brain Size, Development,
and Brain Cell Proliferation
(A) Observation of the formation of the optic lobe
and its neuropils by staining brains with phalloidin
(green, cell membranes) and Hoescht (blue, nuclei)
and neurons (ElaV, red) at different time points
through larval development (hAEL, hours after egg
laying) shows that Sbm downregulation in glia
produces a delay in the development of larval brain
structures. In control brains (top two rows), a group
of ElaV-negative (red) cells is observed at 52 hAEL
(region marked by broken yellow line) in glia Sbm
RNAi-treated larvae (bottom two rows); this is not
observed earlier than the mid-third-instar larval
stage (80–96 hAEL). In control brains, optic lobe
formation is already evident by the early third-
instar (80 hAEL, broken yellow lines), and the optic
lobe (L) and medulla (M) neuropils are already
formed in mid-third-instar larvae (96 hAEL). In Sbm
RNAi-treated larvae, optic lobe formation seems to
occur between 96 and 102 hAEL, and neuropils are
seen at 120 hAEL. It is important to note that while
structures form, they do not seem to have the
regularity observed in controls.
(B) Representative pictures showing proliferating
cells (PH3, green) and glial cells (Repo, magenta)
in the brain of control Repo > Dcr2 (top row)
and Repo > SbmRNAi Dcr2 (bottom row) larvae
at 96 and 120 hAEL.
(C) Quantification of the number of proliferating
cells (top) and the number of glial cells
(bottom) (two-way ANOVA and Duncan post-test,
p < 0.0001, F = 34.33 and F = 37.96; n = 3–6).
Points with different letters signify that they are
significantly different (p < 0.05); data represent
mean ± SEM. hAEL, hours after egg laying.and Nishimura, 2015; Sousa-Nunes et al., 2011). If Sbm also
functions as an amino acid sensor, then its downregulation
should produce effects similar to those caused by a the lack of
Slif (i.e., decreased dilp6 expression and reduced activation of
the IIS pathway [target of Dilp6] in the whole brain and reduced
production of Dilp5 in insulin-producing cells [IPCs] of the
brain; Okamoto and Nishimura, 2015). Contrary to this predic-
tion, the expression level of dilp6 or the direct target of the IIS
pathway, thor, were not affected in Repo > SbmRNAi larvae,
meaning that the pathway is equally active in the brain of
RNAi-treated larvae and controls (Figure 5C). Moreover, the
mRNA levels of the two Dilps produced in IPCs, dilp5 and
dilp2, were almost doubled in the Repo > SbmRNAi larvaeCell Reports(Figure 5D). It has been described that
levels of the Dilp2 immunoreactive signal
are inversely correlated with its release
into the circulation from the producing
cells (Ge´minard et al., 2009). We found
that Repo > SbmRNAi larvae show a
lower immunoreactive Dilp2 signal in
IPCs (Figure 5E), suggesting that the
release of this peptide is augmented in
Repo > SbmRNAi larvae.In conclusion, Sbm functions in Dilp6+ glia, but a reduction of
Sbm levels in all glia does not act negatively on dilp6 expression
and function. This suggests that Sbm in glial cells could regulate
developmental timing and growth through a different effector.
sbm Downregulation in Glia Reduces the Levels of Key
Hormones that Control Developmental Timing and
Growth
In D. melanogaster, larval growth rate and the progression of
larval stages are determined by levels of the molting hormone
20-ecdysone (20E). PTTH induces the expression of the genes
that code for the enzymes responsible for synthesizing 20E in
the prothoracic gland (McBrayer et al., 2007; Rewitz et al.,24, 3156–3166, September 18, 2018 3161
Figure 5. Downregulation of sbm in dilp6-
Expressing Glia Partially Reproduces the
Developmental Delay Observed without
Affecting dilp6 Levels
(A) Proportion of larvae pupated through timewhen
overexpressing Dcr2 or SbmRNAi, Dcr2 in dilp6-
expressing cells (Dilp6-Gal4) either alone or com-
bined with Repo-Gal80 (one-way ANOVA; data
were transformed to the reciprocal values to best
fulfill the test criteria, p < 0.0001, F = 15.79; points
with different letters signify that they are signifi-
cantly different [p < 0.05] with Duncan post-test;
n = 4–10).
(B) Idem A but for downregulation of sbm in the fat
body (ppl-Gal4) (t-Test, t = 1.29; n = 4).
(C and D) Transcription levels of thor and dilp6 (C)
and dilp2 and dilp5 (D) (expressed in copy number)
in the brain of 102 hAEL third-instar larvae after
downregulation of sbm in all glia (Repo-Gal4)
(t test, thor t = 0.57, dilp6 t = 0.54, dilp2 t = 4.25,
and dilp5 t = 3.25; *p < 0.05; **p < 0.001; n = 4).
(E) Dilp2 immunoreactive signal levels in the somas
of insulin-producing cells (IPCs) 22 hr after the
second- to third-instar molt in control and Repo >
SbmRNAi larvae (t test, t = 3.27; **p < 0.001;
n = 28). The percentage in the graph indicates the
difference with respect to controls.
(E0) Representative z stack images of each geno-
type that illustrate the differences in Dilp2 levels.
In all graphs, error bars represent SEM and n.s.
indicates nonsignificant differences.2009). A good proxy for assessing the levels of ecdysone pro-
duction are the transcriptional levels of the genes of its synthesis
pathway, such as neverland and spookier (Figure 6A) (McBrayer
et al., 2007). We found that in control animals, the transcriptional
levels of both genes rise until themoment of wandering, while the
levels of these genes are lower in Repo > SbmRNAi larvae than
controls at every time point. Most importantly, in Repo >
SbmRNAi larvae, spookier transcriptional levels never reach
the peak levels attained by controls at 37 hr after the L2–L3
molt (Figure 6B). Also, transcript levels of the ecdysone receptor
(EcRA), an ecdysone-target gene (Varghese and Cohen, 2007),
are reduced in 96 hAEL Repo > SbmRNAi larvae (24 hr after
L2–L3 molt) relative to controls (Figure S6B). Taken together,
these results strongly suggest that 20E production in sbm
mutant larvae is reduced.
Systemic circulating Dilps activate the IIS pathway in the pro-
thoracic gland (PG), a part of the ring gland (RG), increasing its
size and increasing 20E levels (Colombani et al., 2005; Mirth
et al., 2005). We measured the size of the RG in 102 hAEL larvae
and did not find statistically significant differences between
Repo > SbmRNAi larvae and controls (Figure 6C). This indicates
that the increased Dilp expression and release observed (Figures
5D and 5E) do not significantly affect RG growth; hence, alter-
ations in the transcription of the 20E synthesis genes should
not be a consequence of Dilp signaling. Therefore, we hypothe-
sized that alterations on PTTH levels may be responsible for the
reduction in the transcription of 20E synthesis genes levels
observed.
Because peak levels of PTTH are normally attained a few
hours before peak transcriptional levels of ecdysone synthesis3162 Cell Reports 24, 3156–3166, September 18, 2018genes (McBrayer et al., 2007), we analyzed somatic PTTH levels
in the brains of larvae at 22 hr after the L2–L3 molt. Immunoreac-
tive signal levels were significantly reduced in RNAi-treated
larvae compared to controls (Figures 6D and S6B). Interestingly,
PTTH signal levels in Repo > SbmRNAi larvae at 46 hr after L2–L3
molting (a time point at which control animals have already pu-
pated) were statistically indistinguishable from those of the con-
trols 24 hr earlier (Figures 6D and S6B), indicating that lower
levels of Sbm in glia do not abolish the rise in PTTH levels but
rather produce a shift in the PTTH peak. This shift is likely the
cause of ecdysone in the RG not reaching the levels needed to
trigger pupation in the stereotypical timing, leading to the 24-hr
prolongation of the larval third-instar observed in these animals
and resulting in a phenotype strongly resembling the recently
described PTTH-null mutants (Shimell et al., 2018).
DISCUSSION
In this work, we have shown that downregulation of sbm in glia
provokes negative effects on developmental timing with conse-
quent alterations in growth, and this effect is specific to the larval
third-instar. This is associated with a delayed PTTH peak and
reduced expression of 20E synthesis and target genes. These
larvae have a significantly smaller brain than controls, with fewer
proliferating cells and normal levels of dilp6 transcription and
activation of the IIS pathway (Figure 7).
Developmental timing and growth are regulated through PTTH
and ecdysone. During the larval third-instar in D. melanogaster,
there is an important developmental checkpoint, the critical
weight (CW), after which starvation will no longer delay pupation.
Figure 6. Effects on Developmental Timing
Are Likely due to Disruption in PTTH and
Ecdysone Levels
(A) As development proceeds, prothoracicotropic
hormone (PTTH) is produced in the brain of the
larva and released in the prothoracic gland (PG),
where it induces the expression of the genes of the
molting hormone ecdysone synthesis pathway.
(B and B0) Transcription levels of spookier (B) and
neverland (B0 ) (expressed in copy number) at
different time points in third-instar larvae (L3),
synchronized at second- to third-instar molt, upon
downregulation of sbm in glia (Repo-Gal4) (two-
way ANOVA with a Duncan post-test; data were
transformed to ln to fulfill the test criteria, p < 0.05,
F = 3.12 and F = 3.93; n = 5).
(C) Photograph depicting the difference in relative
sized between the RG and brain in 102 hAEL larvae
(equivalent to 37 hours after L2–L3 molt) and RG
area measurements expressed in 103 mm2 (t test
t = 0.40; n.s., nonsignificant differences; n = 11).
(D and D0 ) Somatic PTTH (D) and neuronal somatic
Sbm levels (D0; as internal control) at different time
points in synchronized third-instar larvae upon
downregulation of sbm in glia (Repo-Gal4). In both
cases, one-way ANOVA with a Duncan post-test
was used. In (D), p < 0.05, F = 14.46, n = 40–46. In
(D0), p = 0.71, F = 3.37, n = 40–46.
(D00) Representative images of somatic PTTH
(green) levels and Sbm (magenta) levels in the
sbm-expressing neurons.
In all graphs, data represent mean ± SEM, and
different letters signify groups that are significantly
different (p < 0.05) in a Duncan post-test.CW is defined by a rise in the levels of ecdysone, a product of
nutrient-dependent Dilp signaling and rising levels of PTTH
(Mirth and Riddiford, 2007; Nijhout et al., 2014). Lack of PTTH
provokes a shift in the CW and prolongs the growth periods
before and after it (McBrayer et al., 2007; Shimell et al., 2018),
resulting in bigger larvae. The phenotypes we describe in the
present report are consistent with this.
Nature of the Link between Glia and PTTH Neurons
Glial cells regulate the exit from quiescence of neuroblasts in
third-instar larval brain (Lanet et al., 2013; Sousa-Nunes et al.,
2011), allowing for an increase in proliferation and brain size.
This regulation is mediated through two factors produced by
glia: Dilp6 and Jellybelly (Jeb) (Cheng et al., 2011; Sousa-Nunes
et al., 2011). Dilp6 is regulated at the transcriptional level accord-
ing to the nutritional status of the larva (Okamoto and Nishimura,
2015; Sousa-Nunes et al., 2011). Jeb is constitutively produced
in glia and allows for ‘‘brain growth sparing’’ in nutritionallyCell Reportsadverse conditions, permitting the brain
to grow at a higher rate than the rest of
the body (Cheng et al., 2011). Both factors
activate the phosphatidylinositol 3-kinase
(PI3K) signaling pathway in quiescent
neuroblasts; Dilp6 does it through the in-
sulin receptor, while Jeb does it throughthe receptor Alk.We observed that brain growth and proliferation
in the brain are highly impaired in glial-Sbm-deficient larvae,
which could be due to reduced production of either of these
two factors. Since our results indicate that dilp6 transcription
does not appear to be affected in this context, futurework should
focus on Jeb as a likely candidate in mediating the observed
phenotypes. We also observed that PI3K pathway activation
does not appear to be altered by Sbm glial downregulation.
This raises the possibility that another unknown factor is
involved, though it remains to be determined whether the release
of Dilp6 from glial cells, the temporal dynamics of its transcrip-
tion, or the temporal dynamics of PI3K pathway activation are
affected. In any case, we have shown that glial downregulation
of Sbm reduces brain size and that this may be in part due to
reduced proliferation, which at least initially does not affect
glia itself. This could mean that downstream to the glial signals,
neuroblasts communicate with PTTH-producing neurons
during their proliferation, allowing for the coordination of the24, 3156–3166, September 18, 2018 3163
Figure 7. Model
Sbm is expressed in glia of the larva (magenta). Downregulation of Sbm in glia
provokes a delay in the development of the brain and a reduction in its final size
(red arrow); in turn, this impacts the production of PTTH in PTTH neurose-
cretory cells (green) and leads to a reduction in expression of the genes
responsible for the production of ecdysone in the PG (orange). This leads to a
delay in the initiation of wandering and pupation, allowing the larvae an extra
24 hr in which tissues such as the represented wing imaginal disc continue
growing (blue arrows), resulting in larvae and pupae of an increased size with
relatively small brains.progression of brain development with developmental timing,
possibly ensuring that a minimal brain development is achieved
before triggering the processes that indefectibly lead to
pupation.
It is interesting to note that the recently described PTTH-null
mutants (Shimell et al., 2018) show growth phenotypes very
similar to the ones described in the present work, strengthening
our model (Figure 7): a 24-hr delay to pupation in the larval third-
instar without affecting the L2–L3 transition; an increase in larval,
pupal, and adult size; a desynchronization of growth of different
tissues; and altered transcription of ecdysone genes. More
importantly, the PTTH-null mutation does not alter brain size,
which adds to the idea that Sbm function in the glia is necessary
to regulate brain growth, and this in turn regulates develop-
mental timing (Figure 7).
It is important to add that the relationship between glia and
PTTH could potentially be direct and involve close contact
between Sbm+ glia and PTTH-producing neurons. Imaging and
functional experiments should be carried out to explore this
possibility.
Cellular Function of Sbm
Whether the link between glia and PTTH neurons is direct or in-
direct, in both cases, the question that arises is how is the Sbm
amino acid antiporter involved? As a LAT, Sbm could act by
exchanging specific amino acids between the internal brain me-
dium and glia, regulating in this way their relative concentrations3164 Cell Reports 24, 3156–3166, September 18, 2018and ensuring proper cellular functions. Transported amino acids
could be themselves neurotransmitters or precursors for neuro-
transmitters. In this regard, Genderblind, another member of the
SLC7 family expressed in some glia, has been described to regu-
late ambient glutamate levels, impacting neuronal physiology
and social communication (Augustin et al., 2007; Featherstone,
2011; Grosjean et al., 2008; Piyankarage et al., 2008). Also, the
SLC7 antiporter JhI-21 has a similar function in the NMJ (Ziegler
et al., 2016). Alternatively, Sbm could exchange amino acids
against Na+ (Fotiadis et al., 2013) and affect the glial resting
membrane potential and, in doing so, alter the Ca2+ waves
necessary for production and release of Dilp6 (Spe´der and
Brand, 2014). Lastly, Sbm could be transporting amino acids
from the hemolymph and serving to sense the levels of one or
more specific amino acids in the glia, as it has been described
for Minidiscs in IPCs, which transports leucine (Manie`re et al.,
2016). Further investigations describing Sbm amino acid trans-
port capabilities will help to solve its action on PTTH neurons
through glia.
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EXPERIMENTAL MODEL AND SUBJECT DETAILS
Fly stocks and rearing conditions
Flies were reared in food containing 6.5%corn flour, 6.5% yeast extract, 1%Agar-Agar and 3%of a 0.1%Tegosept (Apex) antifungal
solution in ethanol. Rearing temperature was 25C for ubiquitous expression experiments. In all other experiments crosses, ovipo-
sitions and embryo development were carried at 25Cwhile development from the 1st-instar stage onward was conducted at 29C in
constant darkness. In all experiments with larvae, animals used were of unknown gender. In experiments with adult flies, only male
flies were used to avoid variability due to gender dimorphism affecting size. A complete list of fly stocks is given in the Key Resources
Table.
S2 cell culture
Cells were cultured in Schneider’s medium (Invitrogen) containing penicillin (50 u/mL), streptomycin (50 mg/mL) and 10% fetal bovine
serum (FBS), at 28C.
METHOD DETAILS
sbm transcript recognition, cloning and tagging
Total RNA was extracted using Isol-RNA Lysis Reagent (5 Prime) and cDNA synthesized using iScript Select cDNA Synthesis Kit
(BioRad) with OligodT and a Random Primers (for cloning the different mRNAs) or specific primer (for identification of transcripts).
PCR for transcript identification and cloning of different isoforms was done using specific primers listed in Table S1. Amplification
products were purified using NucleoSpin Extract II (Macherey Nagel) and cloned into the TOPO entry vector (Invitrogen).
Protein tagged versions were generated using the primers listed in Table S1, cloned into TOPO vector (Invitrogen) for FLAG
versions or pCR8 vector for HA version, and subcloned into the S2 cell expression vector pMT-DEST48 (Invitrogen) using the
Gateway cloning system (Invitrogen).
Sbm GAL4 and UAS-Sbm cloning
To generate the Sbm-Gal4 transgenic line we analyzed the genome region of the sbm gene with Evoprinter (https://evoprinter.ninds.
nih.gov/), comparing to theD. sechellia,D. yakuba,D. erecta andD. Pseudoobscura sequences and found that there were sections of
the introns of the genewith a degree of conservation that suggested that they could contain regulatory sequences.We cloned into the
TOPO vector (Invitrogen) an approximately 3.4 kb long fragment of the locus including the introns of the RC and RD transcripts, from
the template BACR22I24 (Genebank ID AC022346, obtained from the BAC PAC Resources at the Children’s Hospital Oaklande2 Cell Reports 24, 3156–3166.e1–e4, September 18, 2018
Research Institute) with the primers listed in Table S1. Using the Gateway system (Invitrogen) we subcloned this fragment into the
pBPGAL4.2Uw-2 (a gift from Gerald Rubin, Addgene plasmid #26227, (Pfeiffer et al., 2010) and sent to Genetic Services, Inc.
(MA, USA) for injection into their y, w; attP2 line (location 68A4, chromosome 3L.)
To generate the UAS-Sbm transgenic line, we used the Gateway system (Invitrogen) to subclone the CDS from the TOPO vector
to the pUASg:attB vector (Bischof et al., 2013) and sent to Genetic Services, Inc. (MA, USA) for injection into their y, w; attP2 line
(location 68A4, chromosome 3L.)
Sbm antibody
Polyclonal anti-Sbm antibody was produced by immunization of rabbits with the synthetic peptide EAPETDSSGTGRMRKPLE cor-
responding to amino acids 42-59 of Sbm-PA and PD, and amino acids 51-68 of Sbm-PB and PC (Eurogentec).
S2 cell immunocytology and western blots
Cells were seeded at 0.5 million cells/mL 30 h before transfection in multiwell plates with the same medium, then washed in
Schneider’s medium without FBS and transfected with FuGENE HD Transfection Reagent (Promega) in a ratio of 4.5:1 to sterile
plasmid DNA (0.25 mg/mL). Cells were incubated for 17 h in the medium without FBS followed by 8 h in medium with 10% FBS
and induced for 21 h with 0.5 mM copper sulfate.
For immunocytology cells were seeded on wells containing poly-L-lysine treated coverslips (0.01%, Sigma) before induction. After
induction, they were washed three times with PBS and two times with PBS-Glycine 0.1M. Cells were permeabilized with Cytoperm
(BD-Bioscience) and washed with PBS-Saponin 0.05%. Cells were incubated for 1 h with primary antibodies, then washed and
further incubated with secondary antibodies for 30’ and with Hoechst (1 mg/mL) for 5 minutes to mark nuclei. Cells were mounted
in Fluorescent Mounting Medium (Dako). Images were obtained with a Leica TCS SP2 confocal microscope.
For western blots, transfected cells were scrapped, lysed 30min at 4Cwith 1%Triton X-100 buffer (150mMNaCl; 50mMTris-HCl
pH8; Triton X-100 1%; protease inhibitor Roche, 1 mM PMSF) and total proteins were quantified by Lowry method (‘‘DC Protein
Assay’’ kit from Biorad). Samples were then treated in Laemmli Buffer containing or not reducing agent (700 mM beta-mercaptoe-
thanol; 200mMDTT). Proteins were separated on polyacrylamide gel and then transferred on PVDFmembranes. Themembranewas
probed with mouse anti HA antibody and then with the HRP conjugated secondary antibody, before being revealed with ECL reagent
(Amersham biosciences).
Dissections and Immunostainings
Larval tissues were dissected in PBS and fixed in 4%paraformaldehyde (PFA) for 20min at room temperature (RT), rinsed 3x15min in
PBS with 0.3% Triton X-100 (PT), and blocked with 7% normal goat serum (NGS; Sigma #G9023) for 45 min, followed by incubation
with primary antibody at 4C (overnight, or 48 h to 72 h). Samples were washed 4x15 min in PT, incubated with secondary antidobies
for 2-3 h at RT, washed 4x15min in PT and mounted in Vectashield mounting medium. A list of the primary and secondary antibodies
is listed in Table S2. For Phalloidin (Thermo Fisher Scientific) and Hoescht 33342 (Thermo Fisher Scientific) stainings a working
solution was added together with, or 15 min immediately after secondary antibodies, respectively.
Fluorescence quantification
Images were taken on either a Leica TCS SP2, a Leica TCS SP8 or an LSM 880 Axio Imager 2 Zeiss confocal microscope. All quan-
titative analyses were performed employing FIJI Software. Within each experiment, all pictures were taken employing the same
confocal settings and in the case of the Leica TCS SP8 Confocal microscope, using its Hybrid mode. Sbm signal in neurons, glia
and gut, and somatic PTTH and somatic dilp2 levels were quantified from confocal images. In all cases, we analyzed the mean
gray value, a measurement that is independent of the area.
For quantification of Sbm signal in glial cells, confocal images of brain hemispheres stained against Sbm and REPO were taken
with a 20X objective and an optical zoom of 1.5X using a 1 mm step size. First, a Z projection of 6 stacks showing Sbm+ glial signal
was made. Then, a region of interest (ROI) was selected, adjusting the threshold image in order to mark most of the Sbm+ glial signal.
Mean Sbm fluorescence intensity and area was measured within the ROI created. A rectangle of the same or a higher area was
located outside of glial membrane and used to subtract background signal. For the analysis, we considered the mean gray value
(with the subtracted background signal) a measurement that is independent of the area. The same protocol was applied to measure
Sbm levels in neuronal somas.
The mean gray value of PTTH in somas was quantified from confocal Z stacks of brains stained against Sbm and PTTH. Photos
were obtained with a 20X objective with an optical zoom of 3X using a 0.69 mm step size. The signal of Sbm in neuronal somas was
also quantified to compare its variation to that of PTTH. To compare the different genotypes and developmental times, PTTH values
were normalized to the average PTTH signal of each independent experiment.
For dilp2 immunoreactive analysis within the IPCs, confocal images of brains stained against Dilp2 and FOXO (to better localize
IPCs somas) were taken with a 40X objective and an optical zoom of 3 using a 0.69 mm step size. The mean gray value signal
from Z stacks was measured as before, and data was normalized to the average dilp2 signal of each independent experiment to
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Nuclei of glial cells (anti-Repo) and of dividing cells (anti-PH3) were counted using the Quantitation Module of Volocity 6.3 soft-
ware (Quorum Technologies Inc., Ontario), on LASX average Z projection images of one brain lobe, pre-treated with median filter.
In all cases of fluorescent signal quantification, the sample size is the number of brains measured, each brain is considered a
replicate.
Developmental timing, growth assessment and feeding assays
Crosses were performed in oviposition chambers and eggs collected onto an agar plate supplemented with yeast paste for 4 hours.
Recently hatched 1st-instar larvaewere transferred to rearing vials (60 L1 larvae per vial). The number of pupawas counted and pupal
volume was calculated as previously described (Galagovsky et al., 2014). Each mutant condition and its specific control were as-
sayed strictly at the same time to allow their precise comparisons. Larval and male adult weight was measured with a Sartorius
R160P balance. In the case of larvae, each replicate represents the average of 3 groups of 8 larvae. Virgin males were kept in groups
of 15, left for 2 days at 25C and frozen at 80C until weighted. Wing size measurements were performed as in (Galagovsky et al.,
2014). For feeding assays, larvae of the appropriate agewere transferred to regular food tubes supplemented with 0.5%Brilliant Blue
FCF (Sigma). After 2 h, larvae were recovered, thoroughly rinsed, dried and frozen at 80C in groups of 8. The amount of food in-
gested was determined by absorbance measurement of FCF dye at 625 nm. Three groups of 8 larvae were averaged for each point.
Organ size measurement
Larvae were dissected and fixed in 0.4% PFA. Organs were dissected and mounted in 80% Glycerol in PBS, pictures taken with
a Leica DM5000B microscope and measured using the FIJI software. Fat bodies were previously stained with Sudan Black (Sigma)
following the protocol in (Tennessen et al., 2014). Brain lobe volume was estimated by approximating it to a sphere (V = 4/3p(1/2W)3)
where W is the average of the width of both brain lobes of a same brain.
Real Time PCRs
Total RNA for dilp2, dilp5, dilp6 and thor analysis was prepared from 20 120 hAEL third-instar larval brains per sample. Larvae were
dissected in PBS and brains immediately placed in Isol-RNA Lysis reagent (5-Prime) on ice and then lysed using a TissueLyser
(QIAGEN) and frozen at 80C until use. For spookier and neverland samples were prepared from 8 whole third instar larvae per
sample, carefully synchronized at the second to third instar transition. For sbm 10 whole third instar larvae per sample were used.
4 to 7 independent samples were prepared for each point. In all cases rpl29 was used to normalize. To determine copy number a
standard curve was performed from a mix of equal amounts of all the samples in each experiment.
RNA was treated with DNAase (Thermo Fisher Scientific) and cDNA was synthesized using iScript cDNA synthesis kit (BioRad).
Real Time PCRs were carried out using the IQ SYBR Green Supermix (BioRad) in a MyiQ single-color Real-Time PCR detection sys-
tem (BioRad). Primers used are detailed in Table S1.
QUANTIFICATION AND STATISTICAL ANALYSIS
Statistical analyses were performed with the InfoStat package version 2009 (Grupo InfoStat, FCA, Universidad Nacional de Cordoba,
Argentina). To determine if data met the criteria for ANOVA analysis normality was tested using Shapiro-Wilks test and the homoge-
neity of variance was assessed with Levene’s test. p < 0.05 was considered statistically significant. In the cases were data did not
meet these criteria, transformations were. If transformations were not sufficient to meet the criteria, non-parametric analysis were
performed. For the analysis of pupation curves, each independent replicate, i.e., each vial with 60 initial larvae, was adjusted to a
Gompertz non-linear regression model, and the median time to pupation was estimated. The statistical tests, number of replicates
and special requirements for each experiment, as well as type of data transformation performed if necessary are detailed in the leg-
ends of the corresponding figures.e4 Cell Reports 24, 3156–3166.e1–e4, September 18, 2018
